Before Anthropic's IPO: Why Investors Are Eyeing AGIX ETF
As Anthropic prepares for a public debut, many investors seek exposure to AI beyond private rounds. The AGIX ETF offe...
Which Is Better Glide Path Or Equal Weight
Compare Glide Path and Equal Weight strategies to understand which fits your retirement goals. Learn key differences, risks, and practical steps to apply in your portfolio.
26,443 articles
Small with $2.2 Billion ETF Surges Past Benchmarks
A momentum-driven small-cap ETF with about $2.2 billion in assets again outpaced major benchmarks, drawing investor a...
Inside Seattle Clinic That Treats Tech Addiction Like Heroin
A Seattle-area clinic is adopting a stark, device-free recovery model for tech addiction, with detox programs lasting...
This Vanguard Beating Your S&P ETF: Why Buy Now
Vanguard’s FTSE Developed Markets ETF has posted stronger gains than the S&P 500 in 2026, drawing renewed investor in...
Everyone Agrees That Hate for AI Is Real, Cuban Warns
Investors and economists are linking AI skepticism to job security and wage growth, not just beliefs about technology...
Time Energy Transfer Growth: Is It Time to Buy ET?
Energy Transfer is shifting from a pure yield play to a growth story as key midstream projects advance. This long-for...
Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Commvault Systems' Sold Over: What It Means for Investors
When a company's CFO sells stock, investors watch closely. This analysis dives into Commvault Systems' sold over trad...
Roundhill Memory (DRAM) Before July 10: Is It a Buy?
The AI memory boom has traders watching the Roundhill Memory ETF. With a potential SK Hynix ADR list around July 10, ...
Stock Market Today, Feb.: Novo Nordisk Vivtex Pact
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
Wave Life Sciences Slips as Obesity Data Falls Short
Wave Life Sciences slumped after INLIGHT readouts failed to establish WVE-007 as a solo obesity treatment, triggering...
Buy, Hold, Sell: Oracle Stock at $245 — Is It a Buy?
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status